CN110642976A - Polymer potassium ion fluorescent probe and preparation method and application thereof - Google Patents
Polymer potassium ion fluorescent probe and preparation method and application thereof Download PDFInfo
- Publication number
- CN110642976A CN110642976A CN201910968168.4A CN201910968168A CN110642976A CN 110642976 A CN110642976 A CN 110642976A CN 201910968168 A CN201910968168 A CN 201910968168A CN 110642976 A CN110642976 A CN 110642976A
- Authority
- CN
- China
- Prior art keywords
- potassium ion
- fluorescent probe
- reaction
- ion fluorescent
- potassium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910001414 potassium ion Inorganic materials 0.000 title claims abstract description 92
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 title claims abstract description 75
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 42
- 229920000642 polymer Polymers 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title abstract description 9
- 238000001514 detection method Methods 0.000 claims abstract description 13
- 238000006243 chemical reaction Methods 0.000 claims description 37
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 21
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 15
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 14
- RRHXZLALVWBDKH-UHFFFAOYSA-M trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium;chloride Chemical compound [Cl-].CC(=C)C(=O)OCC[N+](C)(C)C RRHXZLALVWBDKH-UHFFFAOYSA-M 0.000 claims description 11
- 239000003054 catalyst Substances 0.000 claims description 10
- 150000004032 porphyrins Chemical class 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 8
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 7
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 239000000178 monomer Substances 0.000 claims description 5
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 4
- 239000003999 initiator Substances 0.000 claims description 4
- 230000035484 reaction time Effects 0.000 claims description 4
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 claims description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 2
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 4
- 239000000523 sample Substances 0.000 abstract description 22
- 150000003384 small molecules Chemical class 0.000 abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 9
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract description 7
- 238000010526 radical polymerization reaction Methods 0.000 abstract description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 3
- 238000004445 quantitative analysis Methods 0.000 abstract description 3
- 238000005886 esterification reaction Methods 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 230000003834 intracellular effect Effects 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 238000005481 NMR spectroscopy Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000002189 fluorescence spectrum Methods 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 229910021645 metal ion Inorganic materials 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- 239000011591 potassium Substances 0.000 description 6
- 229920003169 water-soluble polymer Polymers 0.000 description 6
- 102000004257 Potassium Channel Human genes 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 108020001213 potassium channel Proteins 0.000 description 5
- 239000012224 working solution Substances 0.000 description 5
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 229940126214 compound 3 Drugs 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000007995 HEPES buffer Substances 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 229940125782 compound 2 Drugs 0.000 description 3
- 231100000433 cytotoxic Toxicity 0.000 description 3
- 230000001472 cytotoxic effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000010453 quartz Substances 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 2
- MFFMQGGZCLEMCI-UHFFFAOYSA-N 2,4-dimethyl-1h-pyrrole Chemical compound CC1=CNC(C)=C1 MFFMQGGZCLEMCI-UHFFFAOYSA-N 0.000 description 2
- LDLCZOVUSADOIV-UHFFFAOYSA-N 2-bromoethanol Chemical compound OCCBr LDLCZOVUSADOIV-UHFFFAOYSA-N 0.000 description 2
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- PAPNRQCYSFBWDI-UHFFFAOYSA-N DMP Natural products CC1=CC=C(C)N1 PAPNRQCYSFBWDI-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 208000019025 Hypokalemia Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 208000024896 potassium deficiency disease Diseases 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 2
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- BWGRDBSNKQABCB-UHFFFAOYSA-N 4,4-difluoro-N-[3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-thiophen-2-ylpropyl]cyclohexane-1-carboxamide Chemical compound CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)C1=CC=CS1 BWGRDBSNKQABCB-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 1
- 208000032841 Bulimia Diseases 0.000 description 1
- 206010006550 Bulimia nervosa Diseases 0.000 description 1
- 206010048610 Cardiotoxicity Diseases 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 208000002682 Hyperkalemia Diseases 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 208000002740 Muscle Rigidity Diseases 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- LFZAGIJXANFPFN-UHFFFAOYSA-N N-[3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-thiophen-2-ylpropyl]acetamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CCC(C=1SC=CC=1)NC(C)=O)C LFZAGIJXANFPFN-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- FNYLWPVRPXGIIP-UHFFFAOYSA-N Triamterene Chemical group NC1=NC2=NC(N)=NC(N)=C2N=C1C1=CC=CC=C1 FNYLWPVRPXGIIP-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 231100000259 cardiotoxicity Toxicity 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008614 cellular interaction Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000002801 charged material Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 210000004895 subcellular structure Anatomy 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- UGNWTBMOAKPKBL-UHFFFAOYSA-N tetrachloro-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(Cl)=C(Cl)C1=O UGNWTBMOAKPKBL-UHFFFAOYSA-N 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
- C08F220/28—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/42—Introducing metal atoms or metal-containing groups
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/14—Macromolecular compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Polymers & Plastics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
技术领域technical field
本发明涉及生物材料技术领域,尤其涉及一种高分子钾离子荧光探针及其制备方法和应用。The invention relates to the technical field of biological materials, in particular to a high molecular potassium ion fluorescent probe and a preparation method and application thereof.
背景技术Background technique
钾离子(K+)是哺乳动物细胞中含量最丰富的金属离子之一,约占人体干重的4%。它在众多生理活动中起着及其重要的作用,包括心脏搏动,肌肉收缩,神经信号传导和肾脏排泄等。K+不仅参与维持细胞内外渗透压和电解质平衡,调节血压,还参与调节整个神经系统生化信号的转导。哺乳动物细胞胞质中K+离子的浓度约为130-180mM,而细胞外的浓度为3.5-5.0mM。正常血清中钾离子水平一直维持在3.5-5.5mM之间,当摄入过量时,通常通过肾脏排泄来清除过多的K+。当血钾浓度高于5.5mM时,统称为高钾血症;在低高浓度(5.5-6.0mM)或中高浓度(6.1-6.9mM)时,常引起恶心,疲劳,肌肉无力,有时还伴随心律失常;当血钾浓度高于7.0时,通常导致心脏骤停甚至死亡。当血钾浓度低于3.5mM时,统称为低钾血症。临床上与低钾血症有关的症状包括:虚弱,麻痹,四肢强直、肠梗阻、恶心、呕吐等。K+浓度异常通常是某些疾病的早期征兆,如酗酒,厌食症,贪食症,心脏病,糖尿病,艾滋病和癌症等。因此,寻找可以特异地研究、测量或实时监测细胞内外钾离子浓度的高灵敏方法对了解病理过程及疾病相关药物的开发及筛选意义重大。Potassium ion (K + ) is one of the most abundant metal ions in mammalian cells, accounting for about 4% of the dry weight of the human body. It plays an extremely important role in numerous physiological activities, including cardiac beating, muscle contraction, nerve signaling and renal excretion. K + is not only involved in maintaining intracellular and extracellular osmotic pressure and electrolyte balance, regulating blood pressure, but also regulating the transduction of biochemical signals in the entire nervous system. The concentration of K + ions in the cytoplasm of mammalian cells is approximately 130-180 mM, while the extracellular concentration is 3.5-5.0 mM. Normal serum potassium levels are maintained between 3.5-5.5 mM, and when ingested in excess, excess K + is usually eliminated by renal excretion. When the serum potassium concentration is higher than 5.5mM, it is collectively referred to as hyperkalemia; at low and high concentrations (5.5-6.0mM) or high concentrations (6.1-6.9mM), it often causes nausea, fatigue, muscle weakness, and sometimes accompanied by Cardiac arrhythmia; when blood potassium levels are above 7.0, cardiac arrest or even death usually results. When the blood potassium concentration is less than 3.5mM, it is collectively called hypokalemia. Symptoms clinically associated with hypokalemia include weakness, paralysis, rigidity, intestinal obstruction, nausea, and vomiting. Abnormal K + concentrations are often an early sign of certain diseases, such as alcoholism, anorexia, bulimia, heart disease, diabetes, AIDS, and cancer, among others. Therefore, it is of great significance to find a highly sensitive method that can specifically study, measure or real-time monitor the intracellular and extracellular potassium ion concentration for understanding the pathological process and the development and screening of disease-related drugs.
近年来荧光型钾离子探针已得到一定的发展。荧光钾离子传感器可进行荧光成像容易得到靶分子的时空信息,并且可以非侵入的方式直接测量细胞内钾离子浓度,还可以观察细胞内钾离子的流动和动态平衡,更重要的是可在单细胞以及亚细胞结构水平上对活细胞进行分析,无毒且对细胞无损伤,容易小型化,后处理容易。因此,荧光钾离子传感器是分析和检测钾离子的重要途径,受到了科研工作者的广泛关注和喜爱。In recent years, fluorescent potassium ion probes have been developed to some extent. The fluorescent potassium ion sensor can perform fluorescence imaging to easily obtain the spatiotemporal information of the target molecule, and can directly measure the intracellular potassium ion concentration in a non-invasive manner, and can also observe the flow and dynamic balance of intracellular potassium ions. The analysis of living cells at the level of cellular and subcellular structures is non-toxic and non-destructive to cells, easy to miniaturize, and easy to post-processing. Therefore, fluorescent potassium ion sensor is an important way to analyze and detect potassium ion, which has received extensive attention and love from scientific researchers.
虽然钾离子探针有了一定的发展,但可适合于测量细胞内钾离子(浓度约为130-180mM)的探针还比较有限。在报道的为数不多的细胞内钾离子探针中多以小分子为主。但是,一些小分子探针的水溶性和生物相容性较差,且测试须在含有0.5mM十六烷基三甲基溴化铵(CTAB,表面活性剂)的HEPES溶液中进行。CTAB有较大的细胞毒性,无法在细胞成像过程中使用。Although potassium ion probes have been developed to some extent, the probes suitable for measuring intracellular potassium ions (at a concentration of about 130-180 mM) are still relatively limited. Among the few reported intracellular potassium ion probes, most of them are small molecules. However, some small molecule probes have poor water solubility and biocompatibility, and the test must be performed in HEPES solution containing 0.5 mM cetyltrimethylammonium bromide (CTAB, surfactant). CTAB is highly cytotoxic and cannot be used during cell imaging.
CN106929008B公开了一种高分子钾离子荧光探针及其制备方法和应用,该发明的高分子钾离子荧光探针以苯基氮杂-18-冠-6-胺为识别基团,以半菁染料基团为荧光基团,具有对环境敏感、水溶性好,检测准确度高,对钾离子浓度变化响应迅速等优点,是一种比色的、即时的比率型钾离子检测探针,可制备为检测试纸,根据试纸颜色变化实现钾离子含量高低的快速检测,本发明的高分子钾离子荧光探针有望在中药注射液和红酒及人体尿液或血液等方面检测钾离子浓度,具有广阔的应用前景。该发明中的小分子探针的水溶性较低,且测试需要在CTAB存在下进行,无法在细胞成像过程使用。CN106929008B discloses a high-molecular potassium ion fluorescent probe and its preparation method and application. The high-molecular potassium ion fluorescent probe of the invention uses phenylaza-18-crown-6-amine as a recognition group, and uses hemicyanine as a recognition group. The dye group is a fluorescent group, which has the advantages of being sensitive to the environment, good water solubility, high detection accuracy, and rapid response to changes in potassium ion concentration. It is prepared as a detection test paper, and the rapid detection of potassium ion content is realized according to the color change of the test paper. The polymer potassium ion fluorescent probe of the present invention is expected to detect the potassium ion concentration in traditional Chinese medicine injections, red wine, human urine or blood, etc., and has a wide range of applications. application prospects. The small molecule probe in the invention has low water solubility, and the test needs to be carried out in the presence of CTAB, which cannot be used in the cell imaging process.
CN104910894B公开了一种苯并咪唑类hERG钾离子通道的小分子荧光探针及其制备方法与应用。在hERG钾离子通道及其高表达的肿瘤细胞或组织标记中、在hERG钾离子通道抑制剂的高通量筛选以及在新药心脏毒性评价中以及在作为识别hERG钾离子通道的探针以及在hERG钾离子通道生理、病理及相关疾病研究中的应用。但是该小分子探针水溶性较差,且该类探针的检测限范围有待进一步提升。CN104910894B discloses a small molecule fluorescent probe of benzimidazole-based hERG potassium ion channel, and a preparation method and application thereof. In the hERG potassium channel and its highly expressed tumor cell or tissue markers, in the high-throughput screening of hERG potassium channel inhibitors and in the evaluation of new drugs for cardiotoxicity, and as a probe for the recognition of hERG potassium channels and in hERG Application of potassium channels in the study of physiology, pathology and related diseases. However, the small molecule probes have poor water solubility, and the detection limit of such probes needs to be further improved.
因此,本领域亟待开发一种具有较高的水溶性和生物相容性的高分子钾离子荧光探针,且保证探针所需的钾离子选择性,并满足细胞内钾离子的检测要求。Therefore, there is an urgent need in the art to develop a polymer potassium ion fluorescent probe with high water solubility and biocompatibility, which can ensure the potassium ion selectivity required by the probe and meet the detection requirements of intracellular potassium ions.
发明内容SUMMARY OF THE INVENTION
针对现有技术的不足,本发明的目的之一在于提供一种高分子钾离子荧光探针,尤其在于提供一种比率型高分子钾离子荧光探针,特别涉及一种双色比率型高分子钾离子荧光探针。所述高分子钾离子荧光探针具有较高的水溶性和生物相容性,测试过程中无需用到细胞毒性较大的试剂,且对钾离子的选择性高,对钾离子响应在1-200mM之间,满足细胞内钾离子检测的要求。In view of the deficiencies of the prior art, one of the objectives of the present invention is to provide a high molecular potassium ion fluorescent probe, especially to provide a ratio type high molecular potassium ion fluorescent probe, especially a two-color ratio type high molecular potassium fluorescent probe Ion fluorescent probes. The macromolecular potassium ion fluorescent probe has high water solubility and biocompatibility, does not need to use reagents with greater cytotoxicity in the test process, and has high selectivity to potassium ions, and the response to potassium ions is 1- 200mM, which meets the requirements of intracellular potassium ion detection.
为达此目的,本发明采用如下技术方案:For this purpose, the present invention adopts following technical scheme:
本发明提供一种高分子钾离子荧光探针,所述高分子钾离子荧光探针具有P1所示的结构;The present invention provides a high-molecular potassium ion fluorescent probe, and the high-molecular potassium ion fluorescent probe has the structure shown by P1;
所述b1+b2=b,且所述b2不为0;the b 1 +b 2 =b, and the b 2 is not 0;
所述a:b:c:d=(659-709):240:(50-100):1,例如660:240:(50-100):1、670:240:(50-100):1、680:240:(50-100):1、690:240:(50-100):1、700:240:(50-100):1、(659-709):240:60:1、(659-709):240:70:1、(659-709):240:80:1、(659-709):240:90:1等;The a:b:c:d=(659-709):240:(50-100):1, for example 660:240:(50-100):1, 670:240:(50-100):1 , 680:240:(50-100):1, 690:240:(50-100):1, 700:240:(50-100):1, (659-709):240:60:1, ( 659-709):240:70:1, (659-709):240:80:1, (659-709):240:90:1, etc.;
所述n为1-11的整数,例如1、2、3、4、5、7、9、10等。The n is an integer of 1-11, such as 1, 2, 3, 4, 5, 7, 9, 10, and the like.
本发明提供的高分子钾离子荧光探针P1由小分子钾离子荧光探针KS-23与水溶性高分子侧链连接而成,相较于小分子钾离子探针KS-23,P1的水溶性及生物相容性显著提升,且无需在含有细胞毒性较大的表面活性剂的缓冲溶液中进行测试,可以保证细胞成像过程;并且,P1对钾离子的选择性高,不受其他离子的干扰,且对钾离子响应在1-200mM之间,满足细胞内钾离子检测的要求;The macromolecular potassium ion fluorescent probe P1 provided by the present invention is formed by linking the small molecule potassium ion fluorescent probe KS-23 and the water-soluble polymer side chain. Compared with the small molecule potassium ion probe KS-23, the water-soluble P1 The stability and biocompatibility are significantly improved, and there is no need to test in a buffer solution containing more cytotoxic surfactants, which can ensure the cell imaging process; and, P1 has high selectivity for potassium ions and is not affected by other ions. interference, and the response to potassium ions is between 1-200mM, which meets the requirements of intracellular potassium ion detection;
此外,P1中引入甲基丙烯酰氧乙基三甲基氯化铵结构单元是为了利用正电材料和带负电的细胞相互作用达到增强材料被细胞内吞的能力,并引入发射红色荧光卟啉基团(Porphylin MA,1H NMR(400MHz,Chloroform-d)δ9.04-8.80(m,8H),8.54-8.23(m,10H),7.79(d,J=6.8Hz,9H),6.30(d,J=4.3Hz,1H),5.71(s,1H),4.74(d,J=51.3Hz,4H),2.08(s,3H),-2.69(s,2H))作为内参,在实际使用时,无需再另外加入内参,可用比色法更加准确测量钾离子浓度,获得了比率型高分子钾离子荧光探针。In addition, the introduction of methacryloyloxyethyltrimethylammonium chloride structural unit in P1 is to utilize the interaction between positively charged materials and negatively charged cells to enhance the ability of materials to be endocytosed by cells, and to introduce red fluorescent porphyrins group (Porphylin MA, 1 H NMR (400 MHz, Chloroform-d) δ 9.04-8.80 (m, 8H), 8.54-8.23 (m, 10H), 7.79 (d, J=6.8Hz, 9H), 6.30 ( d, J=4.3Hz, 1H), 5.71(s, 1H), 4.74(d, J=51.3Hz, 4H), 2.08(s, 3H), -2.69(s, 2H)) as internal reference, in practice When there is no need to add additional internal reference, the potassium ion concentration can be measured more accurately by colorimetric method, and a ratio-type high molecular potassium ion fluorescent probe is obtained.
本发明不限定P1中四种结构单元的排列方式,可以是无规排列,也可以是嵌段排列等。The present invention does not limit the arrangement of the four structural units in P1, which may be random arrangement, block arrangement or the like.
本发明提供的荧光探针P1中,部分或全部甲基丙烯酸结构单元的羧基上接枝有KS-23,因此存在b1和b2,且b2不能为0,b1可以为0(全部甲基丙烯酸结构单元的羧基上接枝有KS-23),也可以不为0(部分甲基丙烯酸结构单元的羧基上接枝有KS-23)。In the fluorescent probe P1 provided by the present invention, part or all of the carboxyl groups of the methacrylic acid structural units are grafted with KS-23, so there are b 1 and b 2 , and b 2 cannot be 0, and b 1 can be 0 (all The carboxyl group of the methacrylic acid structural unit is grafted with KS-23), and may not be 0 (KS-23 is grafted on the carboxyl group of some methacrylic acid structural units).
优选地,所述a:b1:c:d:b2=(659-709):239:(50-100):1:1。Preferably, the a:b 1 :c:d:b 2 =(659-709):239:(50-100):1:1.
本发明优选部分甲基丙烯酸结构单元的羧基上接枝有KS-23,且未接枝有KS-23的甲基丙烯酸结构单元与接枝KS-23的甲基丙烯酸结构单元的比例为239:1,即b1:b2=239:1,这样的结构更有利于提高钾离子探针的选择性。The carboxyl group of the preferred part of the methacrylic acid structural unit of the present invention is grafted with KS-23, and the ratio of the methacrylic acid structural unit not grafted with KS-23 to the methacrylic acid structural unit of the grafted KS-23 is 239: 1, that is, b 1 :b 2 =239:1, such a structure is more conducive to improving the selectivity of the potassium ion probe.
优选地,所述a:b:c:d=684:240:75:1。Preferably, the a:b:c:d=684:240:75:1.
优选地,所述a:b1:c:d:b2=684:239:75:1:1。Preferably, the a:b 1 :c:d:b 2 =684:239:75:1:1.
优选地,所述高分子钾离子荧光探针的数均分子量为4000~100000,例如4200、4300、4400、4500、4600、4700、4800、5000、10000、20000、30000、40000、50000、60000、70000、80000、90000等。Preferably, the number-average molecular weight of the macromolecular potassium ion fluorescent probe is 4000-100000, such as 4200, 4300, 4400, 4500, 4600, 4700, 4800, 5000, 10000, 20000, 30000, 40000, 50000, 60000, 70000, 80000, 90000 etc.
本发明的目的之二在于提供一种目的之一所述的高分子钾离子荧光探针的制备方法,所述制备方法包括如下步骤:The second object of the present invention is to provide a preparation method of the macromolecular potassium ion fluorescent probe described in one of the objects, and the preparation method comprises the following steps:
(1)使聚乙二醇单甲醚甲基丙烯酸甲酯(OEG500MA)、甲基丙烯酸(MA)、甲基丙烯酰氧乙基三甲基氯化铵(METAC)和卟啉单体(Porphylin-MA)反应得到聚合物OEG-1,反应式如下:(1) Make polyethylene glycol monomethyl ether methyl methacrylate (OEG 500 MA), methacrylic acid (MA), methacryloyloxyethyltrimethylammonium chloride (METAC) and porphyrin monomers (Porphylin-MA) reaction obtains polymer OEG-1, and the reaction formula is as follows:
(2)使聚合物OEG-1与化合物KS-23反应得到所述高分子钾离子荧光探针,反应式如下:(2) The polymer OEG-1 is reacted with the compound KS-23 to obtain the polymer potassium ion fluorescent probe, and the reaction formula is as follows:
所述b1+b2=b,且所述b2不为0;the b 1 +b 2 =b, and the b 2 is not 0;
所述a:b:c:d=(659-709):240:(50-100):1;The a:b:c:d=(659-709):240:(50-100):1;
所述n为1-11的整数。The n is an integer of 1-11.
本发明通过自由基聚合的方法制备方法得到水溶性高分子骨架OEG-1,OEG-1中的羧基与KS-23中的羟基进行酯化反应,将KS-23通过化学键嫁接到OEG-1上得到P1。In the present invention, the water-soluble polymer skeleton OEG-1 is obtained by the preparation method of free radical polymerization, the carboxyl group in OEG-1 is esterified with the hydroxyl group in KS-23, and KS-23 is grafted onto OEG-1 through chemical bond get P1.
优选地,步骤(1)中,所述反应在引发剂存在下进行。Preferably, in step (1), the reaction is carried out in the presence of an initiator.
优选地,所述引发剂包括偶氮二异丁腈和/或过氧化二苯甲酰。Preferably, the initiator includes azobisisobutyronitrile and/or dibenzoyl peroxide.
优选地,步骤(1)中,所述反应的溶剂包括N,N-二甲基甲酰胺和/或四氢呋喃。Preferably, in step (1), the solvent for the reaction includes N,N-dimethylformamide and/or tetrahydrofuran.
优选地,步骤(1)中,所述反应的温度为60-70℃,例如61℃、62℃、63℃、64℃、65℃、66℃、67℃、68℃、69℃等,优选65℃。Preferably, in step (1), the temperature of the reaction is 60-70°C, such as 61°C, 62°C, 63°C, 64°C, 65°C, 66°C, 67°C, 68°C, 69°C, etc., preferably 65°C.
优选地,所述反应的时间为14-18h,例如14.5h、15h、15.5h、16h、16.5h、17h、17.5h等,优选16h。Preferably, the reaction time is 14-18h, such as 14.5h, 15h, 15.5h, 16h, 16.5h, 17h, 17.5h, etc., preferably 16h.
优选地,步骤(1)中,所述聚乙二醇单甲醚甲基丙烯酸甲酯、甲基丙烯酸、甲基丙烯酰氧乙基三甲基氯化铵和卟啉单体的质量比为500:30:(12.5-75):1,例如500:30:13:1、500:30:20:1、500:30:25:1、500:30:30:1、500:30:35:1、500:30:40:1、500:30:45:1、500:30:50:1、500:30:55:1、500:30:60:1、500:30:70:1等,优选为500:30:25:1。Preferably, in step (1), the mass ratio of the polyethylene glycol monomethyl ether methyl methacrylate, methacrylic acid, methacryloyloxyethyltrimethylammonium chloride and porphyrin monomer is 500:30:(12.5-75):1, e.g. 500:30:13:1, 500:30:20:1, 500:30:25:1, 500:30:30:1, 500:30:35 :1, 500:30:40:1, 500:30:45:1, 500:30:50:1, 500:30:55:1, 500:30:60:1, 500:30:70:1 etc., preferably 500:30:25:1.
优选地,步骤(2)中,所述反应在催化剂存在下进行。Preferably, in step (2), the reaction is carried out in the presence of a catalyst.
优选地,所述催化剂包括对二甲氨基吡啶和/或N-羟基琥珀酰亚胺。Preferably, the catalyst comprises p-dimethylaminopyridine and/or N-hydroxysuccinimide.
优选地,步骤(2)中,所述反应在缩合剂存在下进行。Preferably, in step (2), the reaction is carried out in the presence of a condensing agent.
优选地,所述缩合剂包括1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐和/或二环己基碳二亚胺。Preferably, the condensing agent includes 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and/or dicyclohexylcarbodiimide.
优选地,步骤(2)中,所述反应的溶剂包括N,N-二甲基甲酰胺和/或四氢呋喃。Preferably, in step (2), the solvent for the reaction includes N,N-dimethylformamide and/or tetrahydrofuran.
优选地,步骤(2)中,所述反应的温度为35-45℃,例如36℃、37℃、38℃、39℃、40℃、41℃、42℃、43℃、44℃等,优选40℃。Preferably, in step (2), the temperature of the reaction is 35-45°C, such as 36°C, 37°C, 38°C, 39°C, 40°C, 41°C, 42°C, 43°C, 44°C, etc., preferably 40°C.
优选地,步骤(2)中,所述反应的时间为4-8h,例如4h、5h、6h、7h、8h等,优选为6h。Preferably, in step (2), the reaction time is 4-8h, such as 4h, 5h, 6h, 7h, 8h, etc., preferably 6h.
优选地,步骤(2)中,所述聚合物OEG-1和化合物KS-23的质量比为(140-160):1,例如142:1、145:1、147:1、149:1、150:1、152:1、154:1、156:1、158:1等,优选150:1。Preferably, in step (2), the mass ratio of the polymer OEG-1 and the compound KS-23 is (140-160):1, such as 142:1, 145:1, 147:1, 149:1, 150:1, 152:1, 154:1, 156:1, 158:1, etc., preferably 150:1.
步骤(2)中,KS-23的制备方法包括:利用化合物3和化合物3'反应得到所述钾离子探针,反应式如下:In step (2), the preparation method of KS-23 includes: using compound 3 and compound 3' to react to obtain the potassium ion probe, and the reaction formula is as follows:
优选地,所述反应的溶剂包括乙醇、甲苯和苯中的任意一种或至少两种组合。Preferably, the solvent for the reaction includes any one or a combination of at least two of ethanol, toluene and benzene.
优选地,所述反应中加入催化剂,所述催化剂包括哌啶和/或吡啶。Preferably, a catalyst is added to the reaction, and the catalyst includes piperidine and/or pyridine.
优选地,所述反应在回流下进行。Preferably, the reaction is carried out under reflux.
优选地,所述化合物3通过化合物2与2,4-二甲基吡咯反应得到,反应式如下:Preferably, the compound 3 is obtained by reacting the compound 2 with 2,4-dimethylpyrrole, and the reaction formula is as follows:
优选地,所述反应的溶剂包括四氢呋喃、二氧六环、乙腈和二氯甲烷中的任意一种或至少两种组合。Preferably, the solvent for the reaction includes any one or a combination of at least two of tetrahydrofuran, dioxane, acetonitrile and dichloromethane.
优选地,所述反应中加入催化剂,所述催化剂包括三氟乙酸和/或BF3·Et2O。Preferably, a catalyst is added in the reaction, and the catalyst includes trifluoroacetic acid and/or BF 3 ·Et 2 O.
优选地,所述反应中加入脱氢剂,所述脱氢剂包括,3-二氯-5,6-二氰对苯醌和/或四氯对醌。Preferably, a dehydrogenating agent is added in the reaction, and the dehydrogenating agent includes, 3-dichloro-5,6-dicyano-p-benzoquinone and/or tetrachloro-p-quinone.
优选地,所述反应中加入缚酸剂,所述缚酸剂包括三乙胺。Preferably, an acid binding agent is added in the reaction, and the acid binding agent includes triethylamine.
优选地,所述化合物2通过化合物1与2-溴乙醇反应得到,反应式如式III所示:Preferably, the compound 2 is obtained by reacting the compound 1 with 2-bromoethanol, and the reaction formula is shown in formula III:
优选地,所述反应中加入催化剂,所述催化剂包括碘化钾。Preferably, a catalyst is added to the reaction, and the catalyst includes potassium iodide.
优选地,所述反应中加入缚酸剂,所述缚酸剂包括碳酸钾。Preferably, an acid binding agent is added in the reaction, and the acid binding agent includes potassium carbonate.
优选地,所述反应的溶剂包括CH3CN、丙酮和N,N-二甲基甲酰胺中的任意一种或至少两种组合。Preferably, the solvent for the reaction includes any one or a combination of at least two of CH 3 CN, acetone and N,N-dimethylformamide.
本发明的目的之三在于提供一种目的之一所述的高分子钾离子荧光探针在钾离子检测中的应用。The third object of the present invention is to provide the application of the macromolecular potassium ion fluorescent probe described in one of the objects in potassium ion detection.
相较于现有技术,本发明具有如下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
本发明提供的高分子钾离子荧光探针P1由小分子钾离子荧光探针KS-23与水溶性高分子侧链连接而成,相较于小分子的KS-23,水溶性及生物相容性提升,且无需在含有细胞毒性较大的表面活性剂的缓冲溶液中进行测试,可以保证细胞成像过程;并且,P1对钾离子的选择性高,不受其他离子的干扰,且对钾离子响应在1-200mM之间,且通过比率型测试方法对钾离子浓度进行定量分析,满足细胞内钾离子定量检测的要求;The macromolecular potassium ion fluorescent probe P1 provided by the present invention is formed by linking a small molecule potassium ion fluorescent probe KS-23 and a water-soluble macromolecular side chain. Compared with the small molecule KS-23, it is water-soluble and biocompatible. The performance of P1 is improved, and there is no need to test in a buffer solution containing more cytotoxic surfactants, which can ensure the cell imaging process; in addition, P1 has high selectivity for potassium ions, is not interfered by other ions, and is sensitive to potassium ions. The response is between 1-200mM, and the potassium ion concentration is quantitatively analyzed by the ratio test method, which meets the requirements for the quantitative detection of intracellular potassium ions;
此外,P1中引入甲基丙烯酰氧乙基三甲基氯化铵结构单元是为了利用正电材料和呈现负性的细胞相互作用达到增强材料被细胞内屯的能力,并引入发射红色荧光卟啉基团作为内参,在实际使用时,无需再另外加入内参,可用比色法更加准确测量钾离子浓度,获得了双色比率型高分子钾离子探针。In addition, the introduction of the methacryloyloxyethyltrimethylammonium chloride structural unit in P1 is to use the positive charge material and the negative cell interaction to enhance the ability of the material to be internalized by cells, and to introduce red fluorescent porphyrin The linoline group is used as an internal reference. In actual use, there is no need to add another internal reference. The colorimetric method can be used to measure the potassium ion concentration more accurately, and a two-color ratio type macromolecular potassium ion probe is obtained.
附图说明Description of drawings
图1是测试例1中不同K+浓度下P1的紫外可见吸收光谱图。Figure 1 is the UV-Vis absorption spectrum of P1 under different K + concentrations in Test Example 1.
图2a是测试例1中不同K+浓度下P1的荧光发射光谱图。Figure 2a is the fluorescence emission spectrum of P1 under different K + concentrations in Test Example 1.
图2b是测试例1中P1在572nm处的荧光强度随K+浓度的变化图。Fig. 2b is a graph showing the change of the fluorescence intensity of P1 at 572 nm with the concentration of K + in Test Example 1.
图2c是测试例1中P1在572nm和650nm处的荧光强度比值随K+浓度对数值的变化图。Figure 2c is a graph showing the change in the ratio of the fluorescence intensity of P1 at 572 nm and 650 nm with the logarithmic value of K + concentration in Test Example 1.
图3是测试例2中不同金属离子存在下的P1的荧光光谱图。3 is the fluorescence spectrum of P1 in the presence of different metal ions in Test Example 2.
具体实施方式Detailed ways
为便于理解本发明,本发明列举实施例如下。本领域技术人员应该明了,所述实施例仅仅是帮助理解本发明,不应视为对本发明的具体限制。In order to facilitate the understanding of the present invention, examples of the present invention are as follows. It should be understood by those skilled in the art that the embodiments are only for helping the understanding of the present invention, and should not be regarded as a specific limitation of the present invention.
实施例1Example 1
本实施例提供一种高分子钾离子荧光探针P1的制备方法,具体如下:The present embodiment provides a method for preparing a macromolecular potassium ion fluorescent probe P1, which is specifically as follows:
(1)合成聚合物OEG-1(1) Synthetic polymer OEG-1
将聚乙二醇单甲醚甲基丙烯酸甲酯(mPEG350-MMA,1g),甲基丙烯酸(MAA,60mg),甲基丙烯酰氧乙基三甲基氯化铵(METAC,50mg),卟啉单体(Porphylin-MA,2mg)和偶氮二异丁腈(AIBN,20mg)加入到10mL的史莱克(Schlenk)瓶中,加入5mL DMF溶解。用液氮将混合液体冷冻成为固态。重复抽真空,解冻三次之后,通氮气,封闭阀门,65℃油浴中反应16h。反应完毕后,在冰浴条件下,将反应液缓慢滴入到甲醇中,得到白色沉淀。抽滤并甲醇冲洗3遍,得到白色固体OEG-1(959.0mg),经计算得到产率为88.0%;Polyethylene glycol monomethyl ether methyl methacrylate (mPEG350-MMA, 1g), methacrylic acid (MAA, 60mg), methacryloyloxyethyltrimethylammonium chloride (METAC, 50mg), porphyrin Porphylin monomer (Porphylin-MA, 2 mg) and azobisisobutyronitrile (AIBN, 20 mg) were added to a 10 mL Schlenk bottle, and 5 mL of DMF was added to dissolve. The mixed liquid was frozen into a solid state with liquid nitrogen. Repeated vacuuming, thawed three times, passed nitrogen, closed the valve, and reacted in an oil bath at 65 °C for 16 h. After the completion of the reaction, the reaction solution was slowly dropped into methanol under ice bath conditions to obtain a white precipitate. Suction filtration and rinsed with methanol 3 times to obtain a white solid OEG-1 (959.0 mg), and the calculated yield is 88.0%;
结构表征:1H NMR(400MHz,D2O)δ:4.10(s,2H),3.63(d,J=64.5Hz,40H),3.30(s,4H),3.17(s,2H),1.82(s,3H),1.26–0.56(m,7H)。Structural characterization: 1 H NMR (400 MHz, D 2 O) δ: 4.10 (s, 2H), 3.63 (d, J=64.5 Hz, 40H), 3.30 (s, 4H), 3.17 (s, 2H), 1.82 ( s, 3H), 1.26–0.56 (m, 7H).
根据投料比计算得到OEG-1聚合度比约为a:b:c:d=684:240:75:1。The OEG-1 degree of polymerization ratio calculated according to the feed ratio is about a:b:c:d=684:240:75:1.
通过凝胶渗透色谱(Waters 1515,USA)测试得到OEG-1的数均分子量为4832。The number average molecular weight of OEG-1 was 4832 as measured by gel permeation chromatography (Waters 1515, USA).
(2)合成KS-23(2) Synthesis of KS-23
化合物2的合成:将4-羟基苯甲醛(4.8g,0.04mol),2-溴乙醇(4.83g,0.06mol),KI(3.32g,0.02mol)和K2CO3(8.29g,0.06mol)加入到250mL圆底烧瓶中,用80mL乙腈溶解,80℃回流36h。冷却至室温后,减压蒸馏除去乙腈,残留物用CH2Cl2(80mL)萃取3遍,饱和NaCl溶液(80mL)洗3遍。合并有机相,无水硫酸镁干燥,过滤,浓缩,硅胶柱层析分离,流动性为PE(石油醚):EA(乙酸乙酯)=1:2,得白色固体2.5g,产率为35.3%。Synthesis of compound 2: 4-hydroxybenzaldehyde (4.8g, 0.04mol), 2-bromoethanol (4.83g, 0.06mol), KI (3.32g, 0.02mol) and K2CO3 ( 8.29g , 0.06mol ) were combined ) was added to a 250 mL round-bottomed flask, dissolved in 80 mL of acetonitrile, and refluxed at 80 °C for 36 h. After cooling to room temperature, acetonitrile was distilled off under reduced pressure, the residue was extracted three times with CH 2 Cl 2 (80 mL), and washed three times with saturated NaCl solution (80 mL). The organic phases were combined, dried over anhydrous magnesium sulfate, filtered, concentrated, and separated by silica gel column chromatography. The fluidity was PE (petroleum ether):EA (ethyl acetate)=1:2 to obtain 2.5 g of white solid with a yield of 35.3 g. %.
1H NMR(400MHz,Chloroform-d)δ9.79(s,1H),7.76(d,J=8.5Hz,2H),6.95(d,J=8.5Hz,2H),4.17–4.04(m,2H),4.04–3.88(m,2H),3.32(s,1H)。 1 H NMR (400MHz, Chloroform-d) δ 9.79 (s, 1H), 7.76 (d, J=8.5Hz, 2H), 6.95 (d, J=8.5Hz, 2H), 4.17-4.04 (m, 2H) ), 4.04–3.88 (m, 2H), 3.32 (s, 1H).
13C NMR(101MHz,CDCl3)δ191.55,163.96,132.08,129.89,114.83,69.19,61.01。 13 C NMR (101 MHz, CDCl 3 ) δ 191.55, 163.96, 132.08, 129.89, 114.83, 69.19, 61.01.
化合物3的合成:氮气保护下,将化合物2(2.5g,15.06mmol)和2,4-二甲基吡咯(3g,31.63mmol)加入到500mL双颈瓶中,用160mL四氢呋喃溶解,搅拌30min后,加入三氟乙酸(TFA)160μL,反应液颜色由黄变红,搅拌过夜。完毕后,缓慢滴加2,3-二氯-5,6-二氰苯醌(DDQ)(3.74g,16.57mmol)四氢呋喃溶液,3h后,加入三乙胺溶液(60mL)。继续搅拌2h后,滴加BF3·Et2O(60mL)。继续搅拌6h后,减压蒸馏除去大部分溶剂后,用150mL二氯甲烷溶解,稀盐酸洗2遍,饱和碳酸氢钠溶液洗两遍,饱和氯化钠溶液洗两遍,无水硫酸镁干燥,浓缩,硅胶柱层析分离,流动相为PE:EA=2:1得到暗红色固体1.25g,产率为22%。Synthesis of compound 3: under nitrogen protection, compound 2 (2.5 g, 15.06 mmol) and 2,4-dimethylpyrrole (3 g, 31.63 mmol) were added to a 500 mL two-neck flask, dissolved in 160 mL of tetrahydrofuran, and stirred for 30 min. , 160 μL of trifluoroacetic acid (TFA) was added, the color of the reaction solution changed from yellow to red, and the mixture was stirred overnight. After completion, 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) (3.74 g, 16.57 mmol) tetrahydrofuran solution was slowly added dropwise, and after 3 h, triethylamine solution (60 mL) was added. After stirring continued for 2 h, BF3.Et2O (60 mL) was added dropwise. After stirring for 6 hours, most of the solvent was distilled off under reduced pressure, dissolved in 150 mL of dichloromethane, washed twice with dilute hydrochloric acid, twice with saturated sodium bicarbonate solution, twice with saturated sodium chloride solution, and dried over anhydrous magnesium sulfate. , concentrated, separated by silica gel column chromatography, and the mobile phase was PE:EA=2:1 to obtain 1.25 g of dark red solid with a yield of 22%.
1H NMR(400MHz,Chloroform-d)δ7.09(d,J=8.4Hz,2H),6.88(d,J=8.5Hz,2H),5.73(s,2H),4.52(d,J=1.1Hz,1H),4.11–4.06(m,2H),4.00–3.94(m,2H),2.18(s,6H),1.85(s,6H)。 1 H NMR (400 MHz, Chloroform-d) δ 7.09 (d, J=8.4 Hz, 2H), 6.88 (d, J=8.5 Hz, 2H), 5.73 (s, 2H), 4.52 (d, J=1.1 Hz, 1H), 4.11–4.06 (m, 2H), 4.00–3.94 (m, 2H), 2.18 (s, 6H), 1.85 (s, 6H).
13C NMR(101MHz,CDCl3)δ157.03,135.05,129.69,126.48,125.54,114.43,108.65,69.06,61.40,39.43,12.77,11.16。 13 C NMR (101 MHz, CDCl 3 ) δ 157.03, 135.05, 129.69, 126.48, 125.54, 114.43, 108.65, 69.06, 61.40, 39.43, 12.77, 11.16.
化合物KS-23的合成:将化合物3(102.2mg,0.2660mmol)和TAC-CHO(160mg,0.2216mmol)加入到25mL圆底烧瓶中,加入乙醇5mL溶解,再加入哌啶100μL,回流24h。完毕后,冷却至室温,减压蒸馏除去乙醇,用20mL二氯甲烷溶解,饱和食盐水洗三遍(3×40mL),合并有机相,无水硫酸镁干燥,浓缩,硅胶柱层析分离,流动性为DCM:MeOH=75:1,得到深蓝色固体55mg,产率为23%。其中,TAC-CHO通过文献记载的方法制备得到(A fluorescentsensor with high selectivity and sensitivity for potassium in water[J].Journal of the American Chemical Society,2003,125(6):1468-1469)。Synthesis of compound KS-23: Compound 3 (102.2 mg, 0.2660 mmol) and TAC-CHO (160 mg, 0.2216 mmol) were added to a 25 mL round-bottomed flask, 5 mL of ethanol was added to dissolve, and then 100 μL of piperidine was added, and refluxed for 24 h. After completion, it was cooled to room temperature, distilled under reduced pressure to remove ethanol, dissolved in 20 mL of dichloromethane, washed three times with saturated brine (3×40 mL), combined the organic phases, dried over anhydrous magnesium sulfate, concentrated, separated by silica gel column chromatography, and flowed. The ratio was DCM:MeOH=75:1 to give a dark blue solid 55 mg in 23% yield. Among them, TAC-CHO was prepared by the method described in the literature (A fluorescent sensor with high selectivity and sensitivity for potassium in water [J]. Journal of the American Chemical Society, 2003, 125(6): 1468-1469).
1H NMR(400MHz,Chloroform-d)δ7.53(d,J=15.9Hz,1H),7.26–7.01(m,8H),6.89(d,J=8.0Hz,2H),6.67(d,J=8.3Hz,2H),6.61(s,2H),4.34–4.21(m,2H),4.18(t,J=4.4Hz,2H),4.06(q,J=4.7Hz,8H),3.89–3.83(m,2H),3.70(dq,J=29.1,8.4,7.2Hz,16H),3.56–3.42(m,7H),3.40–3.27(m,4H),2.60(s,3H),2.28(d,J=21.7Hz,6H),1.28(s,9H)。 1 H NMR (400 MHz, Chloroform-d) δ 7.53 (d, J=15.9 Hz, 1H), 7.26-7.01 (m, 8H), 6.89 (d, J=8.0 Hz, 2H), 6.67 (d, J = 8.3Hz, 2H), 6.61 (s, 2H), 4.34–4.21 (m, 2H), 4.18 (t, J=4.4Hz, 2H), 4.06 (q, J=4.7Hz, 8H), 3.89–3.83 (m, 2H), 3.70 (dq, J=29.1, 8.4, 7.2Hz, 16H), 3.56–3.42 (m, 7H), 3.40–3.27 (m, 4H), 2.60 (s, 3H), 2.28 (d , J=21.7Hz, 6H), 1.28 (s, 9H).
质谱(HRMS):C61H77O10N5BF2,计算值:1088.57261,理论值:1088.57690。Mass spectrum (HRMS): Calculated for C61H77O10N5BF2 , calcd : 1088.57261 , calcd : 1088.57690 .
(3)合成高分子钾离子荧光探针P1(3) Synthesis of macromolecular potassium ion fluorescent probe P1
取上述白色固体OEG-1 300.0mg,KS-23(2mg),对二甲氨基吡啶(DMAP,50mg)和1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐(EDC-HCl,150mg)加入到圆底烧瓶中,用5mLDMF溶解,40℃反应过夜。反应完毕后,将反应液缓慢滴入到甲醇中,得到白色沉淀,抽滤并用甲醇冲洗3遍,得到淡蓝色固体。将所得固体溶于5mL DMF中溶解,溶液装入透析膜(3500KD)中,透析48h后,将溶液冷冻干燥,得到淡蓝色固体P1。Take the above white solid OEG-1 300.0mg, KS-23 (2mg), p-dimethylaminopyridine (DMAP, 50mg) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride Salt (EDC-HCl, 150 mg) was added to a round-bottomed flask, dissolved with 5 mL of DMF, and reacted at 40°C overnight. After the completion of the reaction, the reaction solution was slowly dropped into methanol to obtain a white precipitate, which was filtered with suction and rinsed three times with methanol to obtain a light blue solid. The obtained solid was dissolved in 5 mL of DMF, and the solution was loaded into a dialysis membrane (3500KD). After dialysis for 48 h, the solution was freeze-dried to obtain a light blue solid P1.
结构表征:1H NMR(400MHz,D2O)δ:4.10(s,2H),3.63(d,J=64.5Hz,40H),3.30(s,4H),3.17(s,2H),1.82(s,3H),1.26–0.56(m,7H)。Structural characterization: 1 H NMR (400 MHz, D 2 O) δ: 4.10 (s, 2H), 3.63 (d, J=64.5 Hz, 40H), 3.30 (s, 4H), 3.17 (s, 2H), 1.82 ( s, 3H), 1.26–0.56 (m, 7H).
根据投料比和紫外可见分光光度法计算其聚合度比a:b1:c:d:b2=684:239:75:1:1。The polymerization degree ratio a:b 1 :c:d:b 2 =684:239:75:1:1 was calculated according to the charging ratio and UV-Vis spectrophotometry.
通过凝胶渗透色谱(Waters 1515,USA)测试得到P1的数均分子量为4854。The number average molecular weight of P1 was 4854 as measured by gel permeation chromatography (Waters 1515, USA).
测试例1传感性质测试Test Example 1 Sensing Properties Test
(1)将高分子钾离子荧光探针P1溶于二甲基亚砜(DMSO)中配置成储备液,用紫外可见分光光度法测量储备液中P1的浓度。加适量的储备液到HEPES缓冲溶液(10mM,PH=7.4)中使P1终浓度为5μM,工作液体积为3mL。将不同K+浓度的工作液分别装于1cm石英皿中进行测试,测量K+浓度为0和150mM区间的紫外可见吸收光谱(如图1所示)。测试紫外可见吸收光谱的仪器为紫外可见分光光度计(Lambda 25,PerkinElmer)。其中,mM指的是mmol/L。(1) The polymer potassium ion fluorescent probe P1 was dissolved in dimethyl sulfoxide (DMSO) to prepare a stock solution, and the concentration of P1 in the stock solution was measured by UV-Vis spectrophotometry. An appropriate amount of the stock solution was added to HEPES buffer solution (10 mM, pH=7.4) to make the final concentration of P1 5 μM, and the working solution volume was 3 mL. The working solutions of different K + concentrations were respectively placed in 1 cm quartz dishes for testing, and the UV-visible absorption spectra in the range of K + concentration of 0 and 150 mM were measured (as shown in Figure 1). The instrument for measuring the UV-Vis absorption spectrum was a UV-Vis spectrophotometer (Lambda 25, PerkinElmer). Wherein, mM refers to mmol/L.
图1是不同K+浓度下P1的紫外可见吸收光谱图,由图1可以看出,内参卟啉的最大吸收峰为419nm,高分子钾离子荧光探针P1的最大吸收为590nm。随着加入150mM K+,419nm处的吸光度基本不变,590nm处的吸光度有明显蓝移,显示P1的三氮穴醚环与钾离子结合以后,给电子能力减弱,PET效应被削弱,导致紫外可见吸收有蓝移。Figure 1 is the UV-visible absorption spectrum of P1 under different K + concentrations. It can be seen from Figure 1 that the maximum absorption peak of the internal reference porphyrin is 419 nm, and the maximum absorption peak of the polymer potassium ion fluorescent probe P1 is 590 nm. With the addition of 150mM K + , the absorbance at 419nm is basically unchanged, and the absorbance at 590nm has a significant blue shift, indicating that after the combination of the triazide ring of P1 and potassium ion, the electron donating ability is weakened, and the PET effect is weakened, resulting in ultraviolet A blue shift in absorption can be seen.
(2)将上述不同K+浓度(0-1000mM)的工作液分别装于1cm四面透光的石英皿中,测量钾离子浓度为0-1000mM区间的荧光光谱(如图2a所示);(2) The working solutions of the above-mentioned different K concentrations ( 0-1000mM ) were respectively installed in a 1cm quartz dish that was transparent on all sides, and the fluorescence spectrum in the range of 0-1000mM was measured for potassium ion concentration (as shown in Figure 2a);
对572nm处的荧光强度进行定量分析(如图2b所示);Quantitative analysis of the fluorescence intensity at 572 nm (as shown in Figure 2b);
对572nm和650nm处的荧光强度比和钾离子浓度对数值做线性分析,(如图2c所示);Perform linear analysis on the ratio of fluorescence intensity at 572nm and 650nm and the logarithm of potassium ion concentration, (as shown in Figure 2c);
测试荧光光谱的仪器为荧光光谱仪(FluoroMax-4,Horiba)。The instrument for measuring the fluorescence spectrum was a fluorescence spectrometer (FluoroMax-4, Horiba).
图2a为不同K+浓度下P1的荧光发射光谱图,图中显示,内参卟啉的最大发射波长为650nm,高分子钾离子荧光探针KS-23的发射波长为572nm。随着钾离子浓度的增加,650nm处的荧光强度基本不变,572nm处的荧光强度不断增强;Figure 2a shows the fluorescence emission spectra of P1 under different K + concentrations. The figure shows that the maximum emission wavelength of the internal reference porphyrin is 650 nm, and the emission wavelength of the macromolecular potassium ion fluorescent probe KS-23 is 572 nm. With the increase of potassium ion concentration, the fluorescence intensity at 650nm remained basically unchanged, and the fluorescence intensity at 572nm continued to increase;
图2b为P1在572nm处的荧光强度随K+浓度的变化图,其中F0为未结合K+之前572nm处的荧光强度,F为结合相应浓度K+之后在572nm处的荧光强度,图2b中显示,该钾离子传感器大约可以引起20倍左右的荧光增幅,从图中可以看到该探针可测量钾离子浓度的范围在1-200mM,可以满足对细胞内钾离子浓度的测量。其中F0为未加入K+之前在572nm处的荧光强度,F为加入相应K+之后在572nm处的荧光强度Figure 2b shows the change of the fluorescence intensity of P1 at 572 nm with the concentration of K + , where F 0 is the fluorescence intensity at 572 nm before unbound K + , and F is the fluorescence intensity at 572 nm after binding the corresponding concentration of K + , Figure 2b It is shown in the figure that the potassium ion sensor can cause a fluorescence increase of about 20 times. It can be seen from the figure that the probe can measure the potassium ion concentration in the range of 1-200mM, which can meet the measurement of intracellular potassium ion concentration. where F 0 is the fluorescence intensity at 572 nm before adding K + , and F is the fluorescence intensity at 572 nm after adding the corresponding K +
图2c为P1在572nm和650nm处的荧光强度比值(F572/F650)随log[K+]的变化图,同时对(F572/F650)与log[K+]进行线性拟合分析发现,F572/F650与log[K+]线性相关(R2=0.995),因此可以根据测量F572/F650得到相应的K+浓度,且该方法不受钾离子浓度的影响,满足细胞内钾离子定量分析的需求。Figure 2c is a graph showing the change of the ratio of fluorescence intensity (F 572 /F 650 ) of P1 at 572 nm and 650 nm with log[K + ], and a linear fitting analysis was performed on (F 572 /F 650 ) and log[K + ] It is found that F 572 /F 650 is linearly related to log[K + ] (R 2 =0.995), so the corresponding K + concentration can be obtained by measuring F 572 /F 650 , and this method is not affected by potassium ion concentration, satisfying Requirements for quantitative analysis of intracellular potassium ions.
测试例2选择性测试Test Case 2 Selective Test
将P1的DMSO储备液加入到HEPES缓冲溶液(10mM,PH=7.4)中,使P1终浓度为5μM,工作液体积为3mL。将含有不同金属离子的工作液分别装于1cm四面透光的石英皿中进行测试,测量不同金属离子Na+(150mM)、Li+(150mM)、Mg2+(2mM)、Ca2+(2mM)、Zn2+(2mM)、Mn2+(50μM)、Cu2+(50μM)和K+(10mM和150mM)、对P1荧光强度的影响,以测试高分子钾离子荧光探针的选择性和特异性结果如图3所示。The DMSO stock solution of P1 was added to HEPES buffer solution (10 mM, pH=7.4) to make the final concentration of P1 5 μM and the working solution volume was 3 mL. The working solutions containing different metal ions were placed in a 1cm quartz dish with light transmission on all sides for testing, and different metal ions Na + (150mM), Li + (150mM), Mg 2+ (2mM), Ca 2+ (2mM) were measured. ), Zn 2+ (2mM), Mn 2+ (50μM), Cu 2+ (50μM) and K + (10mM and 150mM), the effect on the fluorescence intensity of P1 to test the selectivity of the high molecular potassium ion fluorescent probe and specificity results are shown in Figure 3.
图3是不同金属离子存在下的P1的荧光光谱图,图中显示,不同金属离子的荧光光谱曲线基本重合,且钾离子浓度越高,荧光强度越大,证明上述金属离子对高分子钾离子荧光探针P1的荧光强度基本无影响,证明P1具有高度的钾离子选择性。Fig. 3 is the fluorescence spectrum of P1 in the presence of different metal ions. The figure shows that the fluorescence spectrum curves of different metal ions basically overlap. The fluorescence intensity of the fluorescent probe P1 was basically unaffected, which proved that P1 has a high degree of potassium ion selectivity.
总结:Summarize:
实施例1通过自由基聚合反应得到了完全水溶的高分子OEG-1,高分子骨架中含有羧基,可以与小分子钾离子探针KS-23中的羟基进行酯化反应,将KS-23嫁接到水溶性高分子骨架上得到基于水溶性高分子骨架的高分子钾离子荧光探针P1。该探针是以寡聚乙二醇单甲醚甲基丙烯酸酯(OEG500MA)、甲基丙烯酸酯(MMA)、甲基丙烯酰氧乙基三甲基氯化铵(METAC)为骨架,掺杂卟啉作为内参,通过活性自由基聚合和酯化反应得到的水溶性比率型高分子钾离子荧光探针P1。P1对钾离子的选择性和灵敏度高,且不受其它离子的干扰,证明了本发明将小分子探针KS-23嫁接到水溶性高分子骨架上进而改善其水溶性和传感性能的策略是可行的,有效的。利用高分子技术可以获得高水溶性的新材料,可以制备丰富的荧光比率型探针,将丰富探针研究领域。本发明所合成的P1对钾离子响应在1-200mM间,满足细胞内钾离子定量检测的要求。Example 1 A completely water-soluble polymer OEG-1 was obtained by free radical polymerization. The polymer backbone contains carboxyl groups, which can be esterified with the hydroxyl groups in the small molecule potassium ion probe KS-23 to graft KS-23. The polymer potassium ion fluorescent probe P1 based on the water-soluble polymer backbone is obtained on the water-soluble polymer backbone. The probe is based on oligoethylene glycol monomethyl ether methacrylate (OEG 500 MA), methacrylate (MMA), and methacryloyloxyethyltrimethylammonium chloride (METAC) as the backbone. Doping porphyrin as an internal reference, the water-soluble ratio-type high molecular potassium ion fluorescent probe P1 was obtained by living radical polymerization and esterification. The selectivity and sensitivity of P1 to potassium ions are high, and it is not interfered by other ions, which proves the strategy of grafting the small molecule probe KS-23 on the water-soluble polymer backbone in the present invention to improve its water-solubility and sensing performance. It is feasible and effective. Using polymer technology, new materials with high water solubility can be obtained, and abundant fluorescent ratiometric probes can be prepared, which will enrich the field of probe research. The P1 synthesized in the present invention responds to potassium ions in the range of 1-200 mM, which meets the requirement of quantitative detection of intracellular potassium ions.
申请人声明,本发明通过上述实施例来说明本发明的详细工艺设备和工艺流程,但本发明并不局限于上述详细工艺设备和工艺流程,即不意味着本发明必须依赖上述详细工艺设备和工艺流程才能实施。所属技术领域的技术人员应该明了,对本发明的任何改进,对本发明产品各原料的等效替换及辅助成分的添加、具体方式的选择等,均落在本发明的保护范围和公开范围之内。The applicant declares that the present invention illustrates the detailed process equipment and process flow of the present invention through the above-mentioned embodiments, but the present invention is not limited to the above-mentioned detailed process equipment and process flow, that is, it does not mean that the present invention must rely on the above-mentioned detailed process equipment and process flow. Process flow can be implemented. Those skilled in the art should understand that any improvement of the present invention, the equivalent replacement of each raw material of the product of the present invention, the addition of auxiliary components, the selection of specific methods, etc., all fall within the protection scope and disclosure scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910968168.4A CN110642976B (en) | 2019-10-12 | 2019-10-12 | A kind of macromolecular potassium ion fluorescent probe and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910968168.4A CN110642976B (en) | 2019-10-12 | 2019-10-12 | A kind of macromolecular potassium ion fluorescent probe and its preparation method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110642976A true CN110642976A (en) | 2020-01-03 |
CN110642976B CN110642976B (en) | 2021-07-30 |
Family
ID=69012546
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910968168.4A Active CN110642976B (en) | 2019-10-12 | 2019-10-12 | A kind of macromolecular potassium ion fluorescent probe and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110642976B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023013175A1 (en) * | 2021-08-03 | 2023-02-09 | 国立研究開発法人物質・材料研究機構 | Cationic polymer containing porphyrin, tissue marking agent containing same, and photosensitizer |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012154693A (en) * | 2011-01-24 | 2012-08-16 | Takuya Terai | Potassium fluorescent probe |
CN105732919A (en) * | 2016-03-25 | 2016-07-06 | 同济大学 | Preparation method of porphyrin-containing temperature/multi-metal-ion-responsive block copolymer gel |
CN106929008A (en) * | 2017-03-14 | 2017-07-07 | 南方科技大学 | Potassium ion fluorescent probe and preparation method and application thereof |
WO2018013948A1 (en) * | 2016-07-15 | 2018-01-18 | Arizona Board Of Regents On Behalf Of Arizona State University | Mitochondria-targeting fluorescent potassium+ sensor and method of making the same |
-
2019
- 2019-10-12 CN CN201910968168.4A patent/CN110642976B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012154693A (en) * | 2011-01-24 | 2012-08-16 | Takuya Terai | Potassium fluorescent probe |
CN105732919A (en) * | 2016-03-25 | 2016-07-06 | 同济大学 | Preparation method of porphyrin-containing temperature/multi-metal-ion-responsive block copolymer gel |
WO2018013948A1 (en) * | 2016-07-15 | 2018-01-18 | Arizona Board Of Regents On Behalf Of Arizona State University | Mitochondria-targeting fluorescent potassium+ sensor and method of making the same |
CN106929008A (en) * | 2017-03-14 | 2017-07-07 | 南方科技大学 | Potassium ion fluorescent probe and preparation method and application thereof |
Non-Patent Citations (5)
Title |
---|
HIRATA, TOMOYA等: "Development of a potassium ion-selective fluorescent sensor based on 3-styrylated BODIPY", 《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》 * |
KONG, XIANGXING等: "A Highly Selective Mitochondria-Targeting Fluorescent K+ Sensor", 《ANGEWANDTE CHEMIE, INTERNATIONAL EDITION》 * |
ZHOU, XIANFENG等: "A New Highly Selective Fluorescent K+ Sensor", 《JOURNAL OF THE AMERICAN CHEMICAL SOCIETY》 * |
ZHOU, XIANFENG等: "Triazacryptand-based fluorescent sensors for extracellular and intracellular K+ sensing", 《BIOMATERIALS》 * |
田颜清: "有机及高分子钾离子荧光传感材料", 《中国化学会2017年全国高分子学术论文报告会摘要集》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023013175A1 (en) * | 2021-08-03 | 2023-02-09 | 国立研究開発法人物質・材料研究機構 | Cationic polymer containing porphyrin, tissue marking agent containing same, and photosensitizer |
JP7593579B2 (en) | 2021-08-03 | 2024-12-03 | 国立研究開発法人物質・材料研究機構 | Porphyrin-containing cationic polymer, tissue marking agent containing the same, and photosensitizer |
Also Published As
Publication number | Publication date |
---|---|
CN110642976B (en) | 2021-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA3065044C (en) | Polymer dye modification and applications | |
CN104220438B (en) | Diarylamine-based fluorescent probes for detecting peroxynitrite | |
CN110283583B (en) | γ-glutamyl transpeptidase responsive molecular probe and its application | |
EP3760193B9 (en) | Intracellular delivery vehicle | |
CN109336815B (en) | A two-photon fluorescent probe for the detection of hypochlorous acid in the endoplasmic reticulum | |
Rasheed et al. | Rhodol assisted alternating copolymer based chromogenic vesicles for the aqueous detection and quantification of hydrazine via switch-on strategy | |
CN106867511A (en) | A kind of switching mode zinc ion fluorescent and its preparation method and application | |
EP3461814A1 (en) | New polysulfonated fluorescent dyes | |
CN110372829A (en) | The preparation and application of the polymer gel fluorescence probe of azo-based reduction response | |
Pan et al. | Dual pH and oxygen luminescent nanoprobes based on graft polymers for extracellular metabolism monitoring and intracellular imaging | |
CN111138466A (en) | Preparation method of a new type of BODIPY dynamic fluorescent probe and its application in real-time detection of glutathione concentration in living cells | |
CN110642976A (en) | Polymer potassium ion fluorescent probe and preparation method and application thereof | |
CN114539183A (en) | Lipid drop targeting and biological thiol sensitive fluorescent probe for cancer cell tissue diagnosis, preparation and application | |
CN105688230A (en) | Heptamethine indocyanine dye-polyethylene glycol-folate compound, as well as preparation method and application thereof | |
CN113563298A (en) | Water-soluble substituent-containing rhodamine fluorescent dye and preparation method and application thereof | |
CN109503435B (en) | Novel dual-emission fluorescent dye probe and preparation and application thereof | |
CN115448928B (en) | Semi-cyanine rhodamine fluorescent probe and preparation method and application thereof | |
Cui et al. | A water-soluble polymer fluorescent probe via RAFT polymerization for dynamic monitoring of cellular lipid droplet levels and zebrafish imaging | |
US9279817B2 (en) | Carbofluorescein lactone ion indicators and their applications | |
CN110437268B (en) | Potassium ion probe and preparation method and application thereof | |
CN111849464B (en) | Polymer fluorescent probe and application thereof | |
CN110642857A (en) | A bifunctional fluorescent probe for detecting viscosity and pH and its preparation and application | |
CN114736199B (en) | Methylene blue-based near-infrared fluorescent probe and synthetic method and application thereof | |
CN115477725A (en) | A polymer fluorescent probe for dynamic monitoring of lipid droplets, synthesis method and application thereof | |
CN112521373B (en) | Multi-modal probe and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |